Transpek Industry Share Price

Transpek Industry Limited is a leading global supplier for chlorinated products to various industry sectors ranging from Pharmaceuticals, Agrochemicals and dyes to pigments. The Company has an excellent experience in manufacturing of products using chlorinated chemistry presenting unending opportunities for supply of intermediates and speciality chemicals suitable for multiple applications. Presently, the Company is is into the manufacturing and export of a range of chemicals servicing the requirements of customers from a diverse range of industries Textiles, Pharmaceuticals, Agrochemicals, Advanced Polymers, etc.Established in October, 1965, Transpek Industry Limited (TIL) went public in Sep.78. It started with the manufacture of acrylic plastic sheets at its plant at Atladra (Vadodra district), Gujarat. In 1969, Company discontinued manufacturing acrylic sheets and started manufacturing chemicals. TIL started off with products like sodium hexameta phosphate, sodium tripoly phosphate, phosphoric acid, etc. In 1978, it expanded to manufacture sodium hydrosulphite (hydro), sodium formaldehyde sulphoxylate (safolite), thionyl chloride and sulphur dioxide, most of these being manufactured for the first time in India. TIL entered the global scenario in 1987 and is a governmentrecognised Export House.The company manufactures a wide range of chemicals and intermediates which include sodium hydrosulphite, sodium formaldehyde sulphoxylate, zinc formaldehyde sulphoxylate (safolin), thionyl chloride, sulphur dichloride, rubber accelerators and the metals recovered include copper and zinc. It is the worlds largest manufacturer of safolite and safolin and also Indias only exporter of thionyl chloride and chloro acetyl chloride.TIL expanded its capacities for rubber chemicals, sodium hydrosulphite and thionyl chloride and had set up a joint venture in China for thionyl chloride.In 199596, a new sulphurdioxide recovery and filling station was commissioned conforming to CCOE requirement. In 199697, it increased the installed capacity of Chlorinated Compounds to 16,200 tpa and in 199899, of rubber and related chemicals to 1,272 MT.A MOU has been signed by the Company, its subsidiary Transpek Metals and Oxides Limited (TMOL) and SILOX. The Company has disinvested its holding in the above company from 39% to 14.93% to Excel Industries Ltd. During 200102 the Sulphoxylates Business of Transpek Industry was transferred to Transpek Metals and Oxides Ltd.The company has expanded the installed capacity of Chlorinated Compound during the year 200304 by 2830 Tonnes and with this expansion,the total capacity has risen to 19700 Tonnes.During the year 200405, the Company commissioned the business of Acid Chloride Plant. The Companys wholly owned subsidiary company viz. Transpek Marketing Ltd, was merged with Company and consequently, all its assets and liabilities were transferred to and vested in the Company through Scheme of Arrangement implemented effective from April 1, 2004, the Appointed Date during FY 200405.In 2005 06, the Company improved technology for the manufacture of Thionyl Chloride (TC) and as a result, increased the installed capacity of TC to19500 TPA. During year 200607, the installed capacity of Thionyl Chloride plant increased to 23% per annum. Continuous process improvements resulted in reduction in costs and in effluent and byproducts generation. Debottlenecking of the SO3 plant resulted in an increase in its capacity to 12% p.a. By strengthening RD activities, three new products were added to the product slate of the Company during the year.A whollyowned subsidiary called Transpek Industry (Europe) Ltd. was established in the United Kingdom effective on April 24, 2008. During FY 200809, production was increased by capacity addition due to debottlenecking, efficiency improvement, recovery of products from residue, implementing newer techniques to handle process and adopting new techniques to convert byproducts into value added products. Resultantly, these measures helped in increasing production, effecting saving in consumption of power and maintenance in market share.The Company acquired 50% holding in a small pharma company, Sam Finechem Ltd (SFL) and accordingly, it deemed to be a subsidiary Company effective from 201011. During FY 201415, the Company divested its investments from Sam Fine O Chem Limited (SFOCL) and hence, SFOCL ceased to be the Subsidiary of the Company w.e.f. 03.01.2015. Later during FY 201920, the Company incorporated a Wholly Owned Subsidiary viz. Transpek Creative Chemistry Private Limited (TCCPL) on 6th January, 2020.The Company has validated 3 new nonacid chloride products with the entry of new manufacturers. It has expanded the business operations to Japan, South America, and Eurasia, reflecting geographic diversification and RDled growth in FY 2025. Transpek has initiatedbasic implementation of data analytics, ML, and AI models within its operations to enhance efficiency and decisionmaking in FY25.

For the full year FY2026–2027, revenue reached ₹645.7 crore and profit touched at ₹45.65 crore.